Views 1,296
Citations 0
Editor's Note
August 2016

Anticoagulation in the Very Old

Author Affiliations
  • 1Department of Internal Medicine, University of California, San Francisco

Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA Intern Med. 2016;176(8):1184. doi:10.1001/jamainternmed.2016.3065

One of the most fraught choices clinicians make is deciding which older patients should receive anticoagulant therapy. Risk of thrombosis and bleeding both increase with age, and these risks must be balanced with the burdens of anticoagulant monitoring, cost, adherence, and polypharmacy.1 Studies evaluating the net benefit of anticoagulation therapy often exclude the oldest and sickest patients. Consequently, physicians caring for older adults with complex medical conditions instead must rely on extrapolated data and clinical experience; surveys show that patient age acts as a significant deterrent to the use of anticoagulation regardless of other risk factors.2

First Page Preview View Large
First page PDF preview
First page PDF preview